1733 Stock Overview
Researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Apex Biotechnology Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$30.00 |
| 52 Week High | NT$44.45 |
| 52 Week Low | NT$26.00 |
| Beta | 0.50 |
| 11 Month Change | -8.12% |
| 3 Month Change | -7.12% |
| 1 Year Change | 14.29% |
| 33 Year Change | 31.58% |
| 5 Year Change | 10.09% |
| Change since IPO | 77.19% |
Recent News & Updates
Recent updates
Apex Biotechnology (TWSE:1733) Will Be Hoping To Turn Its Returns On Capital Around
Aug 06
Apex Biotechnology's (TWSE:1733) Conservative Accounting Might Explain Soft Earnings
Mar 21Apex Biotechnology's (TPE:1733) Returns On Capital Not Reflecting Well On The Business
Apr 17Is Apex Biotechnology (TPE:1733) Using Too Much Debt?
Mar 30Is Apex Biotechnology Corp. (TPE:1733) A Good Fit For Your Dividend Portfolio?
Mar 10Is Apex Biotechnology Corp.'s (TPE:1733) Stock On A Downtrend As A Result Of Its Poor Financials?
Feb 17A Look At Apex Biotechnology's (TPE:1733) Share Price Returns
Jan 27
Returns On Capital At Apex Biotechnology (TPE:1733) Paint An Interesting Picture
Jan 06These 4 Measures Indicate That Apex Biotechnology (TPE:1733) Is Using Debt Safely
Dec 16Is Apex Biotechnology Corp.'s (TPE:1733) 4.5% Dividend Worth Your Time?
Nov 22Shareholder Returns
| 1733 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | 2.6% | 1.8% | -0.6% |
| 1Y | 14.3% | 22.8% | 33.8% |
Return vs Industry: 1733 underperformed the TW Medical Equipment industry which returned 22.8% over the past year.
Return vs Market: 1733 underperformed the TW Market which returned 33.8% over the past year.
Price Volatility
| 1733 volatility | |
|---|---|
| 1733 Average Weekly Movement | 4.0% |
| Medical Equipment Industry Average Movement | 4.8% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in TW Market | 9.4% |
| 10% least volatile stocks in TW Market | 3.0% |
Stable Share Price: 1733 has not had significant price volatility in the past 3 months.
Volatility Over Time: 1733's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | n/a | Thomas Y. Shen | www.apexbio.com |
Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing, and hemoglobin screening systems. It also provides pesticide residue check systems; and care management and tele-health services.
Apex Biotechnology Corp. Fundamentals Summary
| 1733 fundamental statistics | |
|---|---|
| Market cap | NT$3.00b |
| Earnings (TTM) | NT$109.46m |
| Revenue (TTM) | NT$1.71b |
27.4x
P/E Ratio1.8x
P/S RatioIs 1733 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1733 income statement (TTM) | |
|---|---|
| Revenue | NT$1.71b |
| Cost of Revenue | NT$1.21b |
| Gross Profit | NT$500.29m |
| Other Expenses | NT$390.83m |
| Earnings | NT$109.46m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.10 |
| Gross Margin | 29.23% |
| Net Profit Margin | 6.40% |
| Debt/Equity Ratio | 0.3% |
How did 1733 perform over the long term?
See historical performance and comparison